Sanofi SA

Press Release: Dupixent positive phase 3 data in children one to 11 years of age with eosinophilic esophagitis published in NEJM

26 июн 2024 16:30:00 Источник Nasdaq GlobeNewswire

Press Release: Availability of the Q2 2024 Aide-mémoire

25 июн 2024 12:32:52 Источник Nasdaq GlobeNewswire

Press Release: Audrey Duval Derveloy appointed Global Head of Corporate Affairs, member of Sanofi’s Executive Committee

21 июн 2024 02:30:00 Источник Nasdaq GlobeNewswire

Press Release: ISTH: Sanofi advances leadership in hemophilia with new data for ALTUVIIIO and fitusiran

21 июн 2024 00:00:00 Источник Nasdaq GlobeNewswire

Press Release: Sanofi and Biovac spearhead polio vaccine manufacturing capabilities in Africa

20 июн 2024 07:00:00 Источник Nasdaq GlobeNewswire

Sanofi: Information concerning the total number of voting rights and shares – May 2024

12 июн 2024 13:19:27 Источник Nasdaq GlobeNewswire

Press Release: ASCO: Sarclisa is first anti-CD38 to significantly improve progression-free survival in combination with VRd for newly diagnosed transplant-ineligible multiple myeloma in phase 3

03 июн 2024 15:15:00 Источник Nasdaq GlobeNewswire

Press Release: Sanofi launches 2024 global Employee Stock Purchase Plan

31 май 2024 05:00:00 Источник Nasdaq GlobeNewswire

Press Release: Dupixent recommended for EU approval by the CHMP to treat patients with COPD

31 май 2024 00:05:00 Источник Nasdaq GlobeNewswire

Press Release: Update on FDA priority review of Dupixent for the treatment of COPD patients with type 2 inflammation

31 май 2024 00:00:00 Источник Nasdaq GlobeNewswire

Press Release: Sanofi completes acquisition of Inhibrx, Inc.

30 май 2024 08:01:34 Источник Nasdaq GlobeNewswire

Press Release: Sarclisa accepted for FDA priority review for the treatment of transplant-ineligible newly diagnosed multiple myeloma

27 май 2024 00:00:00 Источник Nasdaq GlobeNewswire

Press Release: Sanofi, Formation Bio and OpenAI announce first-in-class AI collaboration

21 май 2024 00:30:00 Источник Nasdaq GlobeNewswire

Sanofi: Information concerning the total number of voting rights and shares - April 2024

20 май 2024 15:54:33 Источник Nasdaq GlobeNewswire

Press Release: Dupixent® late-breaking data from NOTUS confirmatory phase 3 COPD study presented at ATS and published in NEJM

20 май 2024 13:15:00 Источник Nasdaq GlobeNewswire

Press Release: Sanofi adds over €1 billion for biomanufacturing to €2.5 billion already committed in major projects in France to support health sovereignty

13 май 2024 00:00:00 Источник Nasdaq GlobeNewswire

Press Release: Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVID-19 vaccine and develop novel flu-COVID-19 combination vaccines

10 май 2024 01:00:00 Источник Nasdaq GlobeNewswire

Press Release: Beyfortus real-world evidence published in The Lancet shows 82% reduction in infant RSV hospitalizations

02 май 2024 00:00:00 Источник Nasdaq GlobeNewswire

Press Release: Annual General Meeting of April 30, 2024

30 апр 2024 11:00:00 Источник Nasdaq GlobeNewswire

Press Release: Sanofi Q1: robust 7% sales growth driven by launches, underpins full-year guidance

25 апр 2024 00:30:00 Источник Nasdaq GlobeNewswire